India's Covid vaccination drive epitome of power of Sabka Prayas: Mandaviya

India crossed 750 mn vaccinations milestone on September 7, 2021, and achieved a milestone of 1 bn vaccinations on October 21, 2021

Mansukh L Mandaviya
Union Health Minister Mansukh L Mandaviya | (PTI Photo)
ANI General News
2 min read Last Updated : Mar 22 2022 | 11:29 AM IST

As India's cumulative COVID-19 vaccination coverage exceeded 181.56 crore, Union Health Minister Mansukh Mandaviya on Tuesday said that the vaccination journey has been extraordinary and an epitome of the power of 'Sabka Prayas'.

"Powered by the spirit of 'Jan-Bhagidari', India's vaccination journey has been extraordinary and an epitome of the power of 'Sabka Prayas'," he said in a tweet.

The Health Minister also shared the chart of the vaccination journey in the country.

The world's largest COVID vaccination drive began in India on January 16, 2021. In a period of 145 days, India administered 25 crore COVID-19 vaccine doses as of June 9, 2021. On August 4, 2021, the vaccination coverage reached the 50 crore mark.

The new phase of universalization of COVID-19 vaccination commenced on June 21, 2021.

India crossed 75 crore vaccinations milestone on September 7, 2021, and achieved a milestone of 100 crore vaccinations on October 21, 2021.

On December 2, 2021, a total of 125 crore vaccine doses were administered in the country. India on January 9, 2022, crossed the 150 crore vaccine mark while on February 19, India crossed the 175 crore vaccination mark.

As on March 22, COVID-19 vaccination coverage has reached 1,81,56,01,944.

COVID-19 vaccination for the age group 12-14 years was started on March 16, 2022. So far, more than 34 lakh (34,19,633) adolescents have been administered with the first dose of COVID-19 vaccine.

As part of the nationwide vaccination drive, the Government of India has been supporting the States and UTs by providing them COVID vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75 per cent of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronMansukh Lal MandaviyaCoronavirus VaccineVaccineCoronavirus Tests

First Published: Mar 22 2022 | 11:29 AM IST

Next Story